A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis

The Journal of Dermatological Treatment
Robert BissonnetteA Menter

Abstract

Chronic plaque psoriasis is partially mediated by elevation of proinflammatory cytokines, including several within the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway. To evaluate the safety and efficacy of the oral selective JAK1 inhibitor INCB039110 in stable, chronic plaque psoriasis. This was a phase 2, randomized, double-blind, placebo-controlled, dose-escalation study of INCB039110 (100 mg once daily, 200 mg once daily, 200 mg twice daily and 600 mg once daily) for 28 days. The primary endpoint was mean percent change from baseline in the static Physician Global Assessment (sPGA) at day 28. The protocol was institutional review board approved. Of 50 patients, 48 completed the study. At day 28, mean percent reduction from baseline in sPGA was 22.2% for INCB039110 100 mg once daily (p  =  0.270 vs. placebo), 29.4% for 200 mg once daily (p  =  0.118), 35.2% for 200 mg twice daily (p  =  0.053), 42.4% for 600 mg once daily (p  =  0.003) and 12.5% for placebo. Across groups, 11.1% to 45.5% achieved an sPGA score of 1 versus 0% for placebo. INCB039110 was generally well tolerated; the most common treatment-emergent adverse event was nasopharyngitis (18.4%). INCB039110 produced significant improv...Continue Reading

References

Jan 1, 1978·Dermatologica·T Fredriksson, U Pettersson
Nov 25, 2003·The New England Journal of Medicine·Craig L LeonardiUNKNOWN Etanercept Psoriasis Study Group
May 6, 2005·The New England Journal of Medicine·Michael P Schön, W-Henning Boehncke
Jun 14, 2005·The British Journal of Dermatology·K A PappUNKNOWN Etanercept Psoriasis Study Group
Jul 31, 2007·Lancet·Christopher Em Griffiths, Jonathan Nwn Barker
Jul 31, 2007·Lancet·Alan Menter, Christopher Em Griffiths
Oct 16, 2007·Journal of the American Academy of Dermatology·Alan MenterKim Papp
Mar 18, 2009·Immunological Reviews·Kamran GhoreschiJohn J O'Shea
Jul 31, 2009·The New England Journal of Medicine·Frank O NestleJonathan Barker
Jan 1, 2010·The Journal of Investigative Dermatology·Phyllis I SpulsTamar Nijsten
Jan 28, 2012·Journal of the American Academy of Dermatology·Naresh PunwaniAlice Gottlieb
Apr 5, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·X T LimaA B Kimball
Sep 28, 2012·The Journal of Investigative Dermatology·Rosa ParisiUNKNOWN Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team
Jun 3, 2014·Journal of Immunology Research·Leeyen Hsu, April W Armstrong
Jun 19, 2014·The New England Journal of Medicine·Eun Bong LeeUNKNOWN ORAL Start Investigators
Jul 8, 2015·The British Journal of Dermatology·K A PappUNKNOWN OPT Pivotal 1 and OPT Pivotal 2 investigators

❮ Previous
Next ❯

Citations

May 19, 2017·Human Psychopharmacology·Baptiste PignonBenjamin Rolland
Feb 6, 2018·F1000Research·William VainchenkerStefan N Constantinescu
Mar 29, 2018·Current Medicinal Chemistry·Francesca MusumeciSilvia Schenone
Mar 1, 2016·American Journal of Clinical Dermatology·Zenas Z N Yiu, Richard B Warren
Feb 1, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Anniina T VirtanenOlli Silvennoinen
Aug 27, 2019·Frontiers in Immunology·Kata P SzilveszterAttila Mócsai
Dec 19, 2019·Frontiers in Immunology·Farzan SolimaniKamran Ghoreschi
Feb 20, 2020·Journal of Cellular Physiology·Arezoo HosseiniBehzad Baradaran
Oct 28, 2019·Frontiers in Immunology·Michael D HowellPaul A Smith
Mar 17, 2020·Archives of Dermatological Research·Cervantes-Durán ClaudiaGarcía-Pérez Martha-Estrella
Jan 2, 2020·Dermatology and Therapy·Amanda Kvist-HansenLone Skov
Jun 18, 2020·Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia·Dario F D'UrsoKetty Peris
Jan 31, 2021·Lancet·Kamran GhoreschiRobert Sabat
Apr 9, 2021·JCI Insight·Zhenpeng DaiAngela M Christiano
May 1, 2021·International Journal of Dermatology·Christine E JoJennifer Beecker
May 6, 2021·Rheumatology·Ali Berkant AvciGerd Rüdiger Burmester
Jun 3, 2021·Chinese Medical Journal·Wen-Juan ChenXing-Zi Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.